June 17, 2020 / 12:24 PM / 25 days ago

BRIEF-Sagimet Reports Positive Topline Results In 12-Week Nash Phase 2 Clinical Trial Of FASN Inhibitor TVB-2640

June 17 (Reuters) -

* SAGIMET ANNOUNCES POSITIVE TOPLINE RESULTS IN 12-WEEK NASH PHASE 2 CLINICAL TRIAL OF FASN INHIBITOR TVB-2640 Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below